Diabetes Mellitus, Type 2

Diabetes Mellitus, Type 2 is a topic covered in the 5-Minute Clinical Consult.

To view the entire topic, please or purchase a subscription.

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

Medicine Central

-- The first section of this topic is shown below --

Basics

Description

Diabetes mellitus (DM) type 2 is due to a progressive insulin secretory defect in the setting of insulin resistance.

Geriatric Considerations
Monitor elderly for hypoglycemia; adjust doses for renal/hepatic dysfunction and cognitive function; less aggressive glucose targets than in younger patients

Pediatric Considerations
Incidence is increasing and parallels obesity epidemic.

Pregnancy Considerations
Diet, metformin, glyburide, and insulin are all options for treatment of gestational diabetes.

Epidemiology

Incidence
1.5 million new cases in 2015


Prevalence
  • Estimated 23.1 million Americans (7.4% of the population); 90–95% are likely type 2.
  • Higher education associated with lower prevalence

Etiology and Pathophysiology

  • Peripheral insulin resistance and/or defective insulin secretion with increased hepatic gluconeogenesis
  • Genetic factors: monogenic (e.g., PPARγ and insulin gene mutations) and polygenic
  • Obesity (body mass index [BMI] ≥25 kg/m2) and visceral adiposity
  • Gut microbiome changes
  • Drug- or chemical-induced (e.g., glucocorticoids, highly active antiretroviral therapy [HAART], atypical antipsychotics, organ transplant immunosuppressants)

Genetics
  • Genome-wide association studies in progress to identify associated genes; 50% concordance in monozygotic twins
  • Family history is strongly predictive of risk.

Risk Factors

  • Gestational diabetes or history of baby with birth weight ≥4 kg (9 lb)
  • Polycystic ovary syndrome (PCOS)
  • Hypertriglyceridemia or low high-density lipoprotein (HDL)—marker for insulin resistance
  • Ethnicity: African American, Latino, Native American, Asian, and Pacific Islander
  • Sedentary lifestyle
  • Use of thiazides, antipsychotics, glucocorticoids, and statins

General Prevention

  • Maintenance of normal weight, or weight loss of 7% body weight, exercise 150 min/week, and decrease in carbohydrates and overall caloric intake. Moderate-intensity exercise and resistance training are recommended.
  • Higher intake of nuts, coffee, tea, and yogurt (1)[A]
  • Use of metformin and thiazolidinediones (TZDs) in select patients with prediabetes (1)[A].

Commonly Associated Conditions

Hypertension, dyslipidemia, metabolic syndrome, fatty liver disease, infertility, PCOS, acanthosis nigricans, hemochromatosis

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Diabetes Mellitus, Type 2 ID - 116181 ED - Baldor,Robert A, ED - Domino,Frank J, ED - Golding,Jeremy, ED - Stephens,Mark B, BT - 5-Minute Clinical Consult, Updating UR - https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/116181/all/Diabetes_Mellitus__Type_2 PB - Wolters Kluwer ET - 27 DB - Medicine Central DP - Unbound Medicine ER -